secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2022-06-07T23:59:59+00:00
Accession:  0000950170-22-011282
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma stockholders elect four Class I directors, approve say-on-pay and auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Four Class I directors elected: Michael Dybbs, John G. Freund, Heidi Hunter, Jon Wigginton, each to serve three-year terms.
- Ratification of Ernst & Young as independent auditor for FY2022 approved with 43,752,354 votes for, 11,569 against.
- Advisory vote on named executive officer compensation (say-on-pay) approved with 40,921,442 for, 759,278 against.
- Stockholders selected one-year frequency for future advisory votes on executive compensation; board adopts annual frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017022011282/0000950170-22-011282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017022011282/stro-20220606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer